StockData
Eupraxia Pharmaceuticals Inc. logo

Eupraxia Pharmaceuticals Inc. (EPRX) stock

EPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 13, 2026Score 5/30
$6.21−0.41 (-6.19%)

Close on Nov 18, 2026Market cap $374.43MP/E –Yield –

Eupraxia Pharmaceuticals net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2025 it was -$38.58M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$38.58M–
FY2024Dec 31, 2024-$25.50M–
FY2023Dec 31, 2023-$28.22M–
FY2022Dec 31, 2022-$18.49M–

More Eupraxia Pharmaceuticals figures

See a number that looks wrong?